Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation
Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation
Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical Management of Dyslipidemia 9,31,32,33<br />
Addressing dyslipidemia is a key component in preventing long term cardiovascular disease in<br />
individuals with type 2 diabetes. Many patients with diabetes have elevated cholesterol values,<br />
which can lead to greater risk of developing cardiovascular disease or acute cardiovascular events.<br />
Diabetic dyslipidemia is a recognizable and modifiable patient risk factor that should be identified<br />
and treated early to prevent complications.<br />
Published by the National Heart Lung and Blood Institute (NHLBI), the ATP III guidelines are an<br />
evidence-based set of recommendations that focus on intensive cholesterol-lowering therapy. The<br />
guidelines address the primary prevention of coronary heart disease (CHD) in persons with multiple<br />
risk factors by managing elevated patient cholesterol levels to reach goal. The ATP III <strong>Guidelines</strong><br />
At-a-Glance Quick Desk Reference which outlines the step by step sequence of cholesterol<br />
management has been provided. The NHLBI and the American <strong>Diabetes</strong> Association recommend<br />
prescribing lifestyle modifications and cholesterol lowering medications to reach the following<br />
target (optimal) adult cholesterol levels:<br />
Targeting <strong>Adult</strong> Cholesterol Levels<br />
Table TABLe 23: Classification 23 Classification of Lipid of Lipid Profile Risk<br />
LDL Cholesterol – Primary Target of Therapy (mg/dL)<br />